Kappac Pharma last-minute Real Value cannot be determined due to lack of data. The latest price of Kappac Pharma is 112.85. Based on Macroaxis valuation methodology, the firm cannot be evaluated at this time. Macroaxis forecasts value of Kappac Pharma from analyzing the firm fundamentals such as Current Valuation of 3.17B, Price to Book of
8.97X and Return On Equity of (0.21)% as well as examining its technical indicators and Probability Of Bankruptcy. In general, we recommend to purchase undervalued stocks and to get rid of overvalued stocks since at some point entities prices and their ongoing real values will merge together.
|Horizon||30 Days Login to change|
Kappac Pharma Total Value AnalysisKappac Pharma Ltd is now anticipated to have takeover price of 3.17B with market capitalization of 3.41B, debt of 4.96M, and cash on hands of 243.84M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Kappac Pharma fundamentals before making investing decisions based on the enterprise value of the company
Kappac Pharma Asset UtilizationKappac Pharma Ltd secures negative usage of assets of -0.13 %, making only 0.0 for each of assets held by the firm. Inadequate assets utilization conveys that the company is being less effective with each of assets it secures. Strictly speaking assets utilization of Kappac Pharma Ltd shows how discouraging it operates for each spent on its assets.
Kappac Pharma Profitability AnalysisThe company reported revenue of . Net Loss for the year was (786K).
Kappac Pharma is Unknown risk asset. Calculation of real value of Kappac Pharma is based on 2 months time horizon. Increasing Kappac Pharma time horizon generally increases accuracy of value calculation and significantly improves predictive power of the methodology used.